Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane
February 24, 2020 16:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel® Plus...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance
February 19, 2020 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 19, 2020
February 05, 2020 16:05 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year...
Integra Announces Pricing of Convertible Senior Notes
February 04, 2020 19:58 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible...
Integra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes
February 03, 2020 16:01 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has amended and extended its credit facility and commenced a...
Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2019 Revenue Results and 2020 Financial Guidance
January 14, 2020 16:05 ET
|
Integra LifeSciences Holdings Corporation
Fourth quarter 2019 reported revenue is expected to be at or near the low end of the previously communicated guidance range of $395 to $400 million, representing organic revenue growth of slightly...
Integra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 16, 2019 16:01 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief...
Integra LifeSciences to participate in the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019 16:01 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Carrie Anderson, chief...
Integra LifeSciences to participate in the 28th Annual Credit Suisse Healthcare Conference
November 06, 2019 16:01 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the 28th Annual Credit Suisse...
Integra LifeSciences Reports Third Quarter 2019 Financial Results
October 24, 2019 06:00 ET
|
Integra LifeSciences Holdings Corporation
Reported revenues increased 3.6% to $379.1 million; organic revenues increased 4.7% GAAP and adjusted earnings per diluted share were $(0.32) and $0.68, respectively The Company is tightening the...